Practice Guideline Briefs
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2007 Sep 15;76(6):894.
CDC Reports on MRSA Infections Among Patients on Dialysis
Guideline source: Centers for Disease Control and Prevention
Literature search described? No
Evidence rating system used? No
Published source: Morbidity and Mortality Weekly Report, March 9, 2007
Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5609a3.htm
Staphylococcus aureus, a leading cause of bloodstream infections in the United States, has become increasingly resistant to first-line antimicrobial agents. Patients on dialysis are particularly susceptible to methicillin-resistant S. aureus (MRSA) infection.
Compared with the general population, in which MRSA infections occur in only 0.2 to 0.4 per 1,000 persons, patients on dialysis are at high risk of MRSA infection. The Centers for Disease Control and Prevention (CDC) estimates that invasive MRSA infections occurred in 45 out of 1,000 patients on dialysis in 2005; these results indicate a 100-fold higher risk of MRSA infection in these patients.
Patients on dialysis who are older than 50 years are at especially increased risk of infection. The CDC also found that men and blacks on dialysis are at increased risk; of the total number of patients on dialysis who had been infected with MRSA, 57 percent were men, and 56 percent were black.
Those patients on dialysis who have invasive devices or a catheter also are at increased risk; according to the CDC, in the event of infection, 90 percent of those patients required hospitalization, and the in-hospital mortality rate for MRSA was 17 percent. Although the risk of infection in patients with a catheter is high, the risk is intermediate for grafts and low for arteriovenous fistulas.
Physicians should use antimicrobials judiciously to reduce pathogens only after following published guidelines. This is particularly true of vancomycin, because cases of S. aureus resistance to this drug have been reported.
Copyright © 2007 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions